Quality of Life Analysis of Patients Treated with Percutaneous Hepatic Perfusion for Uveal Melanoma Liver Metastases.

T M L TongM FioccoJ J van Duijn-de VreugdJ LutjeboerF M SpeetjensF G J TijlM E SitsenR W M ZoethoutC H MartiniA L VahrmeijerR W van der MeerC S P van RijswijkA R van ErkelE KapiteijnM C Burgmans

Published in: Cardiovascular and interventional radiology (2024)

M-PHP causes fatigue and a decline in physical and role functioning in the 1st weeks after treatment, but GHS returns to baseline levels within 21 days. LEVEL OF EVIDENCE 3: Cohort study.

Keyphrases

liver metastases
physical activity
mental health
minimally invasive
ultrasound guided
sleep quality
contrast enhanced
radiofrequency ablation
gestational age
computed tomography
depressive symptoms